These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5004572)

  • 1. [Determination of heparin and standardization of a rapid method in vitro and in vivo].
    Turpini R; Cipolli PL
    Haematologica; 1971; 56(7):315-25. PubMed ID: 5004572
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin dosage in extracorporeal circulation and its neutralization.
    Nyman D; Thurnherr N; Duckert F
    Thromb Diath Haemorrh; 1975 Feb; 33(1):102-4. PubMed ID: 1118825
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative heparin determination and periodic extracorporeal dialysis.
    Thurnherr N; Thölen H; Duckert F
    Helv Med Acta; 1967 Jan; 33(4):334-43. PubMed ID: 6062925
    [No Abstract]   [Full Text] [Related]  

  • 4. [Present state of heparin therapy].
    Blatrix C; Soulier JP; Vacheron A; Cornu P
    Presse Med (1893); 1969 Mar; 77(15):553-6. PubMed ID: 5796027
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved survival rates in dogs after extracorporeal circulation by improved control of heparin levels.
    Akkerman JW; Runne WC; Sixma JJ; Zimmerman AN
    J Thorac Cardiovasc Surg; 1974 Jul; 68(1):59-65. PubMed ID: 4834066
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

  • 7. Objective assessment of heparin requirements for hemodialysis in humans.
    Ireland H; Lane DA; Curtis JR
    J Lab Clin Med; 1984 Apr; 103(4):643-52. PubMed ID: 6230409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple technique for the measurement of plasma heparin concentration during anticoagulant therapy.
    Marder VJ
    Thromb Diath Haemorrh; 1970 Oct; 24(1):230-9. PubMed ID: 5483963
    [No Abstract]   [Full Text] [Related]  

  • 9. [Heparin kinetics and methods of heparinization during haemodialysis (author's transl)].
    Lopot F
    Cas Lek Cesk; 1980 Feb; 119(5):139-44. PubMed ID: 7379103
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Piatnitskaia GK; Kukaeva EA; Charnaia MA; Charnyĭ ISh
    Anesteziol Reanimatol; 1981; (5):52-6. PubMed ID: 7325386
    [No Abstract]   [Full Text] [Related]  

  • 11. Ex vivo neutralization of unfractionated heparin for assessing overall haemostatic potential in patient plasma.
    Božič-Mijovski M; Vučnik M; Boc V; Blinc A; Stegnar M
    Thromb Res; 2015 May; 135(5):1042-4. PubMed ID: 25805163
    [No Abstract]   [Full Text] [Related]  

  • 12. [Method of control of the artificial heparinization of blood].
    Iunovidova LI; Savina ME; Kukaeva EA
    Lab Delo; 1985; (11):657-9. PubMed ID: 2417016
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum heparin concentration during extracorporeal circulation].
    Neef H; Pauer HD
    Thoraxchir Vask Chir; 1970 Dec; 18(6):497-502. PubMed ID: 5275549
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anticoagulant treatment with heparin].
    Langer B; Wolosker M; Albers MT
    Rev Paul Med; 1982; 99(1):31-2. PubMed ID: 7146741
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of activated coagulation time for controlling the heparinization level during operations with artificial circulation].
    Dement'eva II; Savina ME; Piatnitskaia GKh
    Anesteziol Reanimatol; 1980 Aug; (4):29-32. PubMed ID: 7416544
    [No Abstract]   [Full Text] [Related]  

  • 16. [Control of coagulation in extracorporeal circulation. Importance of the routine use of activated blood coagulation time].
    Evora PR; Brasil JC; Otaviano AG; Margarido EA; Ribeiro PJ; Reis CL; Silva JR; Secches AL
    Arq Bras Cardiol; 1981 Aug; 37(2):89-93. PubMed ID: 7348180
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with Calciparin, a new subcutaneously injectable heparin preparation].
    Sessner HH; Brockhaus W; Kunzmann G; Stingl J
    Med Welt; 1971 Jan; 5():187-91. PubMed ID: 5546024
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of bound heparin in prolonged extracorporeal membrane oxygenation.
    Toomasian JM; Zwischenberger JB; Oram AD; DeSmet GM; Bartlett RH
    Trans Am Soc Artif Intern Organs; 1984; 30():133-6. PubMed ID: 6533877
    [No Abstract]   [Full Text] [Related]  

  • 19. [Heparin in therapeutics (author's transl)].
    Capel P
    Rev Med Brux; 1981 Mar; 2(3):181-9. PubMed ID: 7015442
    [No Abstract]   [Full Text] [Related]  

  • 20. [Method of evaluating the adequacy of heparinization during hemodialysis].
    Sukhanov VA; Zlokazov VB
    Urol Nefrol (Mosk); 1982; (3):42-4. PubMed ID: 7112773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.